Evidence map›Paper›PMID 35680927›Full record

ArticleNature communications2022

An in vitro model of neuronal ensembles.

M Angeles Rabadan, Estanislao Daniel De La Cruz, Sneha B Rao, Yannan Chen, Cheng Gong, Gregg Crabtree, Bin Xu, Sander Markx, Joseph A Gogos, Rafael Yuste and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

M Angeles RabadanDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Estanislao Daniel De La CruzDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Sneha B RaoMortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY, USA.ORCID 0000-0003-2147-3248
Yannan ChenDepartment of Biological Sciences, Columbia University, New York, NY, USA.ORCID 0000-0002-2959-2885
Cheng GongDepartment of Biological Sciences, Columbia University, New York, NY, USA.
Gregg CrabtreeMortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY, USA.
Bin XuDepartment of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Sander MarkxDepartment of Psychiatry, Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA.
Joseph A GogosMortimer B. Zuckerman Mind Brain and Behavior Institute, Columbia University, New York, NY, USA.
Rafael YusteDepartment of Biological Sciences, Columbia University, New York, NY, USA.ORCID 0000-0003-4206-497X
Raju TomerDepartment of Biological Sciences, Columbia University, New York, NY, USA. raju.tomer@columbia.edu.ORCID 0000-0002-4229-2860
Columbia University · USColumbia University Irving Medical Center · US

Funding

IMAGING FUNCTIONAL CONNECTIVITY IN VISUAL CORTEXR01EY011787 · NEI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI YUSTE, RAFAEL · 1998 to 2021
$6.4M
MicroRNA Dysregulation in Pyschiatric Disorders and Cognitive DysfunctionR01MH097879 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2012 to 2021
$5.4M
Effect of GABAergic inhibition of dendritic spines on synaptic pruning in the medial prefrontal cortex during adolescenceR01MH115900 · NIMH · SUNY DOWNSTATE MEDICAL CENTER · PI SMITH, SHERYL S · 2019 to 2023
$3.2M
Deciphering the role of histone methyltransferase SETD1A in schizophrenia susceptibilityR01MH112860 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI GOGOS, JOSEPH A · 2017 to 2021
$2.8M
Integrated Microphysiological System of Cerebral Organoid and Blood Vessel for Disease Modeling and Neuropsychiatric Drug screeningUG3TR002151 · NCATS · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI LEONG, KAM W · 2018 to 2019
$2.6M
A comparative approach for decomposing the mammalian brain architectural complexityDP2MH119423 · NIMH · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI TOMER, RAJU · 2018 to 2018
$2.4M
NCATS NIH HHS UG3 TR002151NEI NIH HHS R01 EY011787NIMH NIH HHS DP2 MH119423NIMH NIH HHS R01 MH097879NIMH NIH HHS R01 MH112860NIMH NIH HHS R01 MH115900
6 · The paper itself

Abstract

Advances in 3D neuronal cultures, such as brain spheroids and organoids, are allowing unprecedented in vitro access to some of the molecular, cellular and developmental mechanisms underlying brain diseases. However, their efficacy in recapitulating brain network properties that encode brain function remains limited, thereby precluding development of effective in vitro models of complex brain disorders like schizophrenia. Here, we develop and characterize a Modular Neuronal Network (MoNNet) approach that recapitulates specific features of neuronal ensemble dynamics, segregated local-global network activities and a hierarchical modular organization. We utilized MoNNets for quantitative in vitro modelling of schizophrenia-related network dysfunctions caused by highly penetrant mutations in SETD1A and 22q11.2 risk loci. Furthermore, we demonstrate its utility for drug discovery by performing pharmacological rescue of alterations in neuronal ensembles stability and global network synchrony. MoNNets allow in vitro modelling of brain diseases for investigating the underlying neuronal network mechanisms and systematic drug discovery.

Indexed as

Brain DiseasesSchizophreniaBrainHistone-Lysine N-MethyltransferaseHumansNeuronsOrganoidsHistone-Lysine N-MethyltransferaseSetd1A protein, human

Identifiers

PMID35680927
PMCPMC9184643
OpenAlexW4281664503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.